КСОСПАТА
Analogs of КСОСПАТА
Find cheaper analogs and generic equivalents for КСОСПАТА.
Active Ingredient: Gilteritinib
Product Overview
About КСОСПАТА
КСОСПАТА is a prescription medication containing the active ingredient Gilteritinib, a tyrosine kinase inhibitor used in the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation.
Key Benefits & Uses
- Treatment of adult patients with relapsed or refractory AML with a FLT3 mutation
- Targeted therapy to inhibit the growth and spread of cancer cells
- May improve overall survival and reduce disease progression in eligible patients
Active Ingredient & Action
Gilteritinib works by selectively inhibiting the activity of the FLT3 tyrosine kinase, a protein involved in the growth and survival of cancer cells. By blocking this protein, КСОСПАТА helps to slow or stop the growth of cancer cells, leading to improved outcomes for patients with AML.
Important Notes
КСОСПАТА is available only by prescription and should be used under the guidance of a qualified healthcare professional. Patients should be closely monitored for signs of adverse effects, including liver damage, QT interval prolongation, and secondary malignancies. It is essential to follow the recommended dosage and administration instructions to minimize the risk of side effects.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.